🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

68+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 68 recruiting trials for “chronic-thromboembolic-pulmonary-hypertension

Phase 1RecruitingNCT06554301

A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension

🏥 China National Center for Cardiovascular Diseases📍 1 site📅 Started Oct 2024View details ↗
Phase 2RecruitingNCT06104228

129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)

👨‍⚕️ Fawaz Alenezi, MD, Duke Univeristy📍 1 site📅 Started Aug 2024View details ↗
Phase 3RecruitingNCT06350032

Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children Diagnosed With PAH

🏥 AOP Orphan Pharmaceuticals AG📍 5 sites📅 Started Jul 2024View details ↗
Enrolling by InvitationNCT06445673

A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients

🏥 AOP Orphan Pharmaceuticals AG📍 18 sites📅 Started Jul 2024View details ↗
RecruitingNCT06567379

Myocardial Work Evaluation in Patients With PAH

🏥 Central Hospital, Nancy, France📍 1 site📅 Started Jul 2024View details ↗
Phase 4RecruitingNCT06715280

Switching of Sildenafil to Riociguat in CTEPH Patients

🏥 Chinese University of Hong Kong📍 1 site📅 Started Jul 2024View details ↗
NARecruitingNCT06569940

Sleepiz One+ vs. Capnography and Electrocardiography

👨‍⚕️ Christian Neumann, Dr. med., Zentrum für Schlafmedizin "Schlaflabor Fluntern"📍 1 site📅 Started Jul 2024View details ↗
Phase 2, PHASE3RecruitingNCT06683040

Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension

👨‍⚕️ Tamila V Martynyuk, MD, E.I.Chazov Cardiology Center📍 1 site📅 Started Jun 2024View details ↗
RecruitingNCT06454838

Exercise Capacity Muscle Oxygenation and Arterial Stiffness in Children With Pulmonary Arterial Hypertension

👨‍⚕️ Meral BOŞNAK GÜÇLÜ, Prof. Dr., Gazi University📍 1 site📅 Started Apr 2024View details ↗
Phase 2, PHASE3Enrolling by InvitationNCT06209710

Balloon Pulmonary Angioplasty vs. Combined Approach With Pulmonary Artery Denervation in CTEPH: Effectiveness Comparison

👨‍⚕️ Slobodan Obradovic, MD, PhD, Clinic of Cardiology, Military Medical Academy, Belgrade, Serbia📍 1 site📅 Started Apr 2024View details ↗
NARecruitingNCT05110066

BPA vs. PEA in CTEPH

👨‍⚕️ Irene Lang, MD,Prof, Medical University of Vienna📍 2 sites📅 Started Apr 2024View details ↗
RecruitingNCT06476470

Taiwan Interstitial Lung Disease Multi-center Investigation and Registry

👨‍⚕️ Pin-Kuei Fu, MD., Ph.D, Taichung Veterans General Hospital📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06286891

Frailty, Physical Capacity and Lung Function in Postoperative Pulmonary Endarterectomy Patients

👨‍⚕️ Rafael M Ianotti, PT, Instituto do Coração - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo📍 1 site📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT06053580

Repurposing Valsartan May Protect Against Pulmonary Hypertension

👨‍⚕️ Peter Leary, MD, PhD, University of Washington📍 1 site📅 Started Feb 2024View details ↗
Phase 2RecruitingNCT06038630

129Xe MRI Cardiopulmonary

👨‍⚕️ Joseph Mammarappallil, MD, Duke University📍 1 site📅 Started Jan 2024View details ↗
Phase 4RecruitingNCT06317805

Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients

🏥 AOP Orphan Pharmaceuticals AG📍 19 sites📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT04778046

Pulmonary Hypertension SOLAR

👨‍⚕️ Sudarshan Rajagopal, MD, PhD, Duke University📍 1 site📅 Started Nov 2023View details ↗
NARecruitingNCT06605794

FreeFlow Percutaneous Atrial Septal Shunt for IPAH

👨‍⚕️ Junbo GE, Prof., Fudan University📍 1 site📅 Started Sep 2023View details ↗
Phase 3RecruitingNCT05824923

A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure

👨‍⚕️ Yaling Han, The General Hospital of Northern Theater Command📍 1 site📅 Started Aug 2023View details ↗
RecruitingNCT05843500

Chronic Thromboembolic Disease Registry

👨‍⚕️ Miles Conrad, MD, University of California, San Francisco📍 1 site📅 Started Aug 2023View details ↗
← PreviousPage 2 of 4Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →